Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative genomic hybridization: uses and limitations.

P Lichter1, S Joos, M Bentz

  • 1Abteilung Organisation komplexer Genome, Deutsches Krebforschungszentrum, Heidelberg, Germany.

Seminars in Hematology
|November 9, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.

Nature communications·2025
Same author

<i>Bordetella pertussis</i> exhibits genomic diversity within patients and laboratory culture.

mSystems·2025
Same author

Can screening and decontamination procedures performed on an outpatient basis reduce colonization with Staphylococcus aureus and mitigate associated complications in patients undergoing elective hospital procedures? A controlled intervention study (STAUfrei).

The Journal of hospital infection·2024
Same author

A randomized controlled trial of acupuncture and receptive music therapy for sleep disorders in the elderly-ELAMUS: study protocol.

BMC complementary medicine and therapies·2024
Same author

Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.

Scientific reports·2023
Same author

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.

ESMO open·2022

Comparative genomic hybridization (CGH) aids lymphoma research by identifying genomic alterations. A new matrix-CGH method using DNA microarrays offers improved diagnostics for leukemia and lymphoma subgroups.

Area of Science:

  • Genomics
  • Oncology
  • Molecular Biology

Background:

  • Comparative genomic hybridization (CGH) is crucial for understanding genomic alterations in hematologic malignancies.
  • Genomic imbalances identified by CGH have validated lymphoma classifications and revealed new pathogenic genes.
  • Traditional CGH on metaphase cells has limitations for routine diagnostics.

Purpose of the Study:

  • To discuss the advancements and applications of matrix-CGH in diagnosing hematologic malignancies.
  • To highlight the potential of matrix-CGH in identifying genetically defined leukemia and lymphoma subgroups.
  • To present ongoing developments in leukemia-specific matrix-CGH DNA chips for clinical use.

Main Methods:

  • Utilizing comparative genomic hybridization (CGH) on DNA microarrays, known as matrix-CGH.

Related Experiment Videos

  • Developing and applying matrix-CGH for the analysis of genomic imbalances in lymphomas and leukemias.
  • Designing leukemia-specific matrix-CGH DNA chips tailored for clinical needs.

    • Main Results:

    • Matrix-CGH overcomes limitations of traditional CGH, enabling new diagnostic approaches.
    • Genomic imbalance patterns confirm existing lymphoma classifications and identify novel genes.
    • Matrix-CGH facilitates the identification of genetically distinct leukemia and lymphoma subgroups.

    Conclusions:

    • Matrix-CGH represents a significant advancement over traditional CGH for hematologic malignancy diagnostics.
    • This technique holds promise for refining classification and identifying therapeutic targets in leukemia and lymphoma.
    • Development of specialized matrix-CGH chips is advancing the clinical application of genomic analysis in hematologic cancers.